#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pancreatic carcinoma metastatic Encephalopathy neonatal Nodal marginal zone B-cell lymphoma Retinopathy proliferative Drug eruption Leukoencephalopathy Laryngeal squamous cell carcinoma Severe myoclonic epilepsy of infancy Neuropathy peripheral Congenital hypotransferrinaemia Immune-mediated renal disorder Dementia Prolymphocytic leukaemia Infection in an immunocompromised host Peripheral primitive neuroectodermal tumour of soft tissue More trials…

    Learn about Rare Diseases

    Antithrombin III deficiency – Trials in Disease Rett syndrome – Treatment Immunodeficiency congenital – Diagnostics Adrenogenital syndrome – Diagnostics Mantle cell lymphoma stage II – Life with Disease Mucopolysaccharidosis III Nephrotic syndrome Niemann-Pick disease – Treatment Lymphatic malformation – Life with Disease Isodicentric chromosome 15 syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tranexamic Acid Hydroxypropyl Cellulose Lf GSKVX000000025896 Human Albumin Solution Tecaginlimab Efepoetin Alfa Betaine Citrate Water For Injections Pravastatin Sodium Venglustat LY3537031 Benfotiamine Imetelstat Sodium Pasireotide Diaspartate Sodium Laurilsulfate Budesonide Azd5004 Lna043 Immunoglobulin G Apl-101 More therapies…

    Learn about Your Condition

    Peripheral ischaemia Primary amyloidosis Haematological infection Meniere's disease Lung adenocarcinoma stage III Pulmonary congestion Pharyngeal cancer stage II Endometrial adenocarcinoma Habitual abortion Anogenital dysplasia Cancer fatigue Burkitt's lymphoma Post procedural swelling Systemic lupus erythematosus Osteopenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Tumor-Infiltrating Lymphocyte Cell Therapy and Aldesleukin for Patients with Advanced Stage Ovarian Cancer as Initial Treatment

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • TIL CELLS
    The Netherlands
  • A Study of Pressurized Aerosol Chemotherapy with Cisplatin and Doxorubicin for Patients with Fluid Buildup Around the Lungs Caused by Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Cisplatin
    • Doxorubicin Hydrochloride
    Italy
  • Long-term safety and effectiveness follow-up study of AB-1005 gene therapy in patients with Parkinson’s disease or multiple system atrophy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Multiple system atrophy
    • Parkinson’s disease
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 2 Encoding Glial Cell Line-Derived Neurotrophic Factor
    • Carbidopa
    • Fluorodopa (18F)
    Poland
  • Treatment of Severe Eye Chemical Burns with Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells for Patients with Severe Ocular Chemical Burns

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Povidone, Iodinated
    • Remifentanil Hydrochloride
    • Human Serum Albumin
    France
  • A study testing inhaled amikacin compared to placebo in critically ill patients with ventilator-associated tracheobronchitis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Amikacin
    France
  • Testing inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Prednisolone Sodium Succinate
    • Dexamethasone Phosphate
    • Vindesine Sulfate
    Austria Czechia Denmark Finland France Germany +5
Previous Page
1 … 746 747 748 749 750 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!